Gilead Sciences, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application ...

Ludhiana district has witnessed an increase in the Human Immunodeficiency Virus (HIV) positive patients and data of the past ...

Life-saving HIV programmes in Lesotho are at risk of collapse following the loss of US foreign aid, more than 30 NGOs warned ...

Lenacapavir is a twice-yearly injectable medication designed to be used as pre-exposure prophylaxis (PrEP). The FDA is giving ...

Scientists believe they are on the cusp of a vaccine for HIV. Two promising vaccines were set to go to additional trials. But ...

The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...

Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...

They are among those who will be the most hurt by the Trump administration’s drastic actions last month to suddenly stop US ...

Researchers have identified key immunological markers associated with mortality in hospitalised people living with HIV/AIDS.

The Ministry of Health warns that the freeze has exposed critical services such as HIV management, vaccine programs, ...

Liberia’s health system has heavily depended on the United States Agency for International Development (USAID). USAID has invested more than three billion dollars in humanitarian, development, and ...

If PEPFAR is not reauthorized for the next four years, and without other resources for the HIV response, there would be 6.3 ...